Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Annals of Surgical Oncology|June 4, 2020
Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced MelanomaLauren S Levine, Kelly M Mahuron, Katy K Tsai, et al.
Molecular Cancer Research : MCR|March 18, 2022
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor ImmunityMia Han, Bianca Nguyen, Jack Y Lee, et al.
Head & Neck|June 18, 2026
Metastatic Lymph Node Status Is Associated With Progression-Free Survival in Oral Cavity Squamous Cell Carcinoma Treated With PembrolizumabAngeline A Truong, Savinnie Ho, Minna K I Apostolova, et al.
JCI Insight|July 21, 2017
Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapyKimberly Loo, Katy K Tsai, Kelly Mahuron, et al.
American Journal of Clinical Oncology|February 21, 2018
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 StudyRoger B Cohen, Jean-Pierre Delord, Toshihiko Doi, et al.
Cancer|August 18, 2016
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodiesAlain P Algazi, Katy K Tsai, Alexander N Shoushtari, et al.
Cancer|January 23, 2024
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancersAlain P Algazi, James Moon, Christopher D Lao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II TrialEzra E W Cohen, Lisle Nabell, Deborah J Wong, et al.
Laryngoscope Investigative Otolaryngology|March 2, 2026
Timely Matters: Predictors of Delay in Oral Cavity Cancer Patients Across the Care ContinuumNicholas Correia, Kennedy Johnson, Megan Durr, et al.
The Journal of Clinical Investigation|August 16, 2016
Tumor immune profiling predicts response to anti-PD-1 therapy in human melanomaAdil I Daud, Kimberly Loo, Mariela L Pauli, et al.
Pageof 5